Medically reviewed by Dr. Frangos, MD
Board-certified physician with over 15 years of experience in hormone optimization and insurance advocacy
Last updated: March 2026

Major insurers such as UnitedHealthcare, Blue Cross Blue Shield, Aetna, and Cigna frequently deny hormone replacement therapy (HRT) claims.

But many denials can be overturned when the right documentation is submitted.

• • 83% of prior authorization appeals are overturned when properly pursued (AMA, 2024)

  • Only 0.2% of denied patients file an appeal (KFF, 2023)

If your hormone therapy was denied, understanding the appeal process can significantly improve your chances of getting coverage.

Book a consultation to review your denial and treatment options.

A Real Example of an HRT Denial That Got Reversed

Last fall, a 38-year-old teacher came to our virtual clinic.

She wasn’t menopausal — she was perimenopausal. Her progesterone levels had dropped significantly. Estradiol was declining, and she was waking up multiple times per night with severe night sweats. Anxiety and fatigue were affecting her daily life.

Her doctor prescribed:

• • Estradiol patches

  • Micronized progesterone

Both prescriptions were denied by Blue Cross Blue Shield of Colorado.

The denial stated that she did not meet criteria for hormone replacement therapy.

However, her lab results clearly showed ovarian insufficiency.

Two appeals were filed on a Thursday. Both were approved by the following Wednesday.

Situations like this are more common than most people realize.

In fact, 69% of people who receive an insurance denial don’t even know they can appeal (KFF, 2023).

If your treatment has been denied, discussing your situation with a provider experienced in hormone therapy and insurance appeals can help clarify your options.

Book a consultation

Why Insurance Companies Deny Hormone Therapy

Insurance denials often follow predictable patterns. Understanding the reason behind the denial can help you build a stronger appeal.

Medical Necessity Disputes

This is the most common reason insurers deny hormone therapy.

Typically this means one of the following:

• • Lab values don’t meet the insurer’s threshold

  • Symptoms are not clearly documented

  • The reviewer does not believe hormone therapy is necessary for the condition

For men experiencing symptoms such as fatigue, low libido, or reduced muscle mass, evaluation for low testosterone may help determine whether treatment is appropriate.

Compounded vs FDA-Approved Hormones

Compounded hormone medications are denied far more frequently than FDA-approved drugs.

Examples include:

• • Compounded testosterone creams

  • Custom estradiol/progesterone combinations

  • Compounded thyroid medications

Because compounded medications are not FDA-approved, insurers often use this as a justification for denying coverage.

Appeals may still succeed if your doctor can demonstrate that no commercially available medication provides the appropriate dose or delivery method.

Step Therapy Requirements

Some insurance companies require patients to try lower-cost medications before approving certain hormone therapies.

Examples include:

If the first-line medication is ineffective or medically inappropriate, your doctor can request a step therapy exception.

Outdated Research Bias

Some insurance policies still rely on interpretations of the 2002 Women’s Health Initiative study, which raised concerns about hormone therapy risks.

However, that study evaluated:

• • synthetic hormones

  • women with an average age of 63

Modern guidelines now distinguish between those treatments and bioidentical hormone therapy started earlier in menopause.

Appeals may reference updated guidance from:

• • North American Menopause Society (NAMS)

  • Endocrine Society

Which Hormone Therapies Are Denied Most Often?

Generally speaking, FDA-approved generic medications are easiest for insurers to approve.

Your Rights When Hormone Therapy Is Denied

Many patients are unaware that federal law protects their ability to appeal insurance decisions.

ACA Appeal Protections

Under the Affordable Care Act, health insurance plans must provide:

State-Specific Protections

Some states provide additional protections.

You can check your state insurance department website for local appeal rules.

The External Review Strategy

If your internal appeal is denied, you may request an external review.

An independent physician evaluates the medical documentation and determines whether the denial was appropriate.

External review decisions are legally binding for insurers.

Across different states, 40–80% of external reviews overturn the original denial.

If you’re unsure whether your denial qualifies for an appeal or external review, speaking with a provider experienced in hormone therapy appeals can help.

Book a consultation

Step-by-Step: How to Appeal a Hormone Therapy Denial

Step 1: Review Your Denial Letter

Your denial letter typically includes:

• • The denial reason code

  • The insurer’s explanation

  • Appeal instructions

  • The appeal deadline

Many plans allow up to 180 days to file an appeal.

Step 2: Gather Supporting Evidence

Your appeal should include documentation such as:

• • Lab test results

  • Symptom documentation

  • Previous treatments attempted

  • Clinical guideline references

  • A physician letter of medical necessity

If you’re unsure what documentation your insurer requires, a specialist can help review your case.

Book a consultation

Step 3: Write the Appeal Letter

A strong appeal letter typically includes:

        1. Patient identification details
2. Reference to the denial notice
3. Symptoms and clinical findings
4. Relevant lab results
5. Medical necessity explanation
6. Request for reconsideration

Helpful resources:

• • Testosterone appeal letter template

  • Estradiol appeal letter template

Step 4: Submit and Track Your Appeal

Once submitted, follow up regularly.

Step 5: Escalate If Necessary

If the internal appeal is denied, you may still:

• • Request a peer-to-peer review between physicians

  • File for external review

  • Contact your state insurance commissioner

Peer-to-peer discussions often help clarify medical necessity and may reverse a denial.

Why Amazing Meds Is Different

Many services focus on only one part of the process.
Some clinics prescribe hormones but do not assist with insurance issues. Other services help fight insurance denials but cannot prescribe treatment.

Amazing Meds offers a more integrated approach.

Our team helps patients with:

• hormone evaluation

• treatment planning

• prior authorizations

• appeal letters

• ongoing treatment management

This approach helps patients navigate both treatment and insurance challenges in one place.

Learn more or schedule a consultation

Frequently Asked Questions

How common are hormone therapy insurance denials?

Prior authorization denials occur in roughly 19% of cases across major insurers. Certain hormone treatments may face higher denial rates.

Can I appeal a denial myself?

Yes. Patients have the right to appeal any insurance denial.

However, appeals supported by a physician letter of medical necessity are often more successful.

How long do hormone therapy appeals take?

What if I need treatment immediately?

Some patients begin treatment while their appeal is ongoing and seek reimbursement later if the appeal is approved.

Discussing your situation with a healthcare provider can help determine the best path forward.

Does Medicare cover hormone therapy?

Medicare Part D may cover certain FDA-approved hormone therapies depending on the plan formulary.

Final Thoughts

Insurance denials for hormone therapy are frustrating, but they are often not the final decision.

Many denials happen because of:

• • missing documentation

  • administrative errors

  • outdated coverage policies

Understanding the appeal process can improve your chances of getting treatment covered.

If you need guidance reviewing your denial or determining the next step, speaking with a hormone specialist may help.

Book a consultation with Amazing Meds

Sources

American Medical Association (AMA). 2024 AMA Prior Authorization Physician Survey.
https://www.ama-assn.org/system/files/prior-authorization-survey.pdf

Kaiser Family Foundation (KFF). Claims Denials and Appeals in ACA Marketplace Plans.
https://www.kff.org/private-insurance/issue-brief/claims-denials-and-appeals-in-aca-marketplace-plans/

MoneyGeek. Health Insurance Claim Denial Rates by State and Insurer.
https://www.moneygeek.com/insurance/health/analysis/health-insurance-denial-rates/

North American Menopause Society (NAMS). The 2022 Hormone Therapy Position Statement.
https://www.menopause.org/publications/professional-publications/position-statements-other-reports

American Urological Association (AUA). Evaluation and Management of Testosterone Deficiency.
https://www.auanet.org/guidelines/guidelines/testosterone-deficiency-guideline

Endocrine Society. Clinical Practice Guidelines for Hormone Therapy.
https://www.endocrine.org/clinical-practice-guidelines

Centers for Medicare & Medicaid Services (CMS). Health Insurance Appeals and External Review.
https://www.cms.gov/CCIIO/Programs-and-Initiatives/Consumer-Support-and-Information/External-Appeals

ProPublica. Health Insurance Claim Denials and Appeals Investigation.
https://www.propublica.org/article/how-often-do-health-insurers-deny-claims